Report cover image

Ophthalmic Drugs Market

Publisher Coherent Market Insights
Published Dec 02, 2025
Length 151 Pages
SKU # CMI20729390

Description

Ophthalmology is a specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology, and diseases that may affect the eye. Whereas, ophthalmic drugs are used to treat various disorders associated with the eyes, such as cataracts, glaucoma, infection, allergy, and inflammation, retinal disorders (such as wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others), and other ophthalmic disorders.

Market Dynamics

Rise in prevalence of ophthalmic disorders, growing geriatric population, rise in demand for safe and effective ophthalmic drugs, rise in focus on the development of ophthalmic drugs, and increase in research and development are major factors expected to propel growth of the global ophthalmic drugs market during the forecast period.

For instance, in April 2022, Sandoz announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, AB-rated generic equivalent to AbbVie’s COMBIGAN, to lower eye pressure in patients with ocular hypertension. Moreover, in March 2022, Théa Pharma acquired seven branded ophthalmic products from Akorn Operating Company LLC to strengthen its position as a significant provider of products developed to satisfy the demands of eye care specialists across the United States.

Key features of the study
  • This report provides in-depth analysis of the global ophthalmic drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global ophthalmic drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG, Pfizer Inc., Bausch & Lomb Incorporated, F. Hoffmann-LA Roche Ltd. (Genentech, Inc.), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global ophthalmic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ophthalmic drugs market.
Market Segmentation
  • Global Ophthalmic Drugs Market, By Indication
  • Dry Eye
  • Glaucoma
  • Infection/Inflammation/Allergy
  • Retinal Disorder
  • Wet Age-related Macular Degeneration
  • Dry Age-related Macular Degeneration
  • Diabetic Retinopathy
  • Others
  • Others
  • Global Ophthalmic Drugs Market, By Type
  • Prescription Drugs
  • Over-the-counter Drugs
  • Global Ophthalmic Drugs Market, By Dosage Form
  • Liquid Ophthalmic Drug Forms
  • Solid Ophthalmic Drug Forms
  • Semisolid Ophthalmic Drug Forms
  • Multicompartment Drug Delivery Systems
  • Other Ophthalmic Drug Forms
  • Global Ophthalmic Drugs Market, By Distribution Channel
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others
  • Global Ophthalmic Drugs Market, By Therapeutic Class
  • Anti-glaucoma
  • Anti-infection
  • Anti-inflammation
  • Anti-allergy
  • Others
  • Global Ophthalmic Drugs Market, By Geography
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
  • Global Ophthalmic Drugs Market: Key Companies Insights
  • Abbvie Inc. (Allergan Plc)
  • Alcon, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Bausch & Lomb Incorporated
  • Hoffmann-LA Roche Ltd. (Genentech, Inc.)

Table of Contents

151 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Indication
Market Snapshot, By Type
Market Snapshot, By Dosage Form
Market Snapshot, By Distribution Channel
Market Snapshot, By Therapeutic Class
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of ophthalmic disorders
Risks associated with ophthalmic drugs
High demand for safe/effective ophthalmic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Ophthalmic Drugs Market, By Indication, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Dry Eye
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Glaucoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Infection/Inflammation/Allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Retinal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Wet Age-related Macular Degeneration
Dry Age-related Macular Degeneration
Diabetic Retinopathy
Others
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
5. Global Ophthalmic Drugs Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Prescription Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Over-the-counter Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
6. Global Ophthalmic Drugs Market, By Dosage Form, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Liquid Ophthalmic Drug Forms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Solid Ophthalmic Drug Forms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Semisolid Ophthalmic Drug Forms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Multicompartment Drug Delivery Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Other Ophthalmic Drug Forms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
7. Global Ophthalmic Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Drug Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
8. Global Ophthalmic Drugs Market, By Therapeutic Class, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Anti-glaucoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Anti-infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Anti-inflammation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Anti-allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
9. Global Ophthalmic Drugs Market, By Geography, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2020-2032,(USD Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2020-2032,(USD Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2020-2032,(USD Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2020-2032,(USD Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2020-2032,(USD Bn)
10. Competitive Landscape
Abbvie Inc. (Allergan Plc)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alcon, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bausch & Lomb Incorporated
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-LA Roche Ltd. (Genentech, Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on Global Ophthalmic Drugs Market” - forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us